Literature DB >> 10355502

Molecular aspects of organic compound transport across the plasma membrane of hepatocytes.

T Kamisako1, E C Gabazza, T Ishihara, Y Adachi.   

Abstract

Many organic compounds are taken up from the blood by membrane transporters, taken across the sinosuidal membrane of hepatocytes and then excreted into bile via the bile canalicular membrane. The hepatic uptake of conjugated bile acids is mediated by the sodium taurocholate cotransporting polypeptide. Many organic anions and bulky organic cations are incorporated into hepatocytes by the organic anion transporting polypeptide, while small organic cations are transported by the organic cation transporter. At the canalicular membrane, organic compounds are excreted into bile by ATP-binding cassette transporters which hydrolyse ATP to ADP. Excretion of monovalent bile acids is mediated by the canalicular bile salt transporter and that of organic anions, including divalent bile acid, conjugates, are mediated by the multi-drug resistance-associated protein 2, also termed canalicular multi-specific organic anion transporter. Organic cations are excreted into bile by the multi-drug resistance gene product (MDR) 1 and phospholipids are excreted by MDR3 (mdr2 in mice and rats). The clinical syndromes associated with alterations of these transporters are also discussed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10355502     DOI: 10.1046/j.1440-1746.1999.01886.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  2 in total

1.  Low heritability in pharmacokinetics of talinolol: a pharmacogenetic twin study on the heritability of the pharmacokinetics of talinolol, a putative probe drug of MDR1 and other membrane transporters.

Authors:  Johannes Matthaei; Mladen V Tzvetkov; Valerie Gal; Cordula Sachse-Seeboth; Daniel Sehrt; Jakob B Hjelmborg; Ute Hofmann; Matthias Schwab; Reinhold Kerb; Jürgen Brockmöller
Journal:  Genome Med       Date:  2016-11-08       Impact factor: 11.117

2.  Selected ABCB1, ABCB4 and ABCC2 polymorphisms do not enhance the risk of drug-induced hepatotoxicity in a Spanish cohort.

Authors:  Eugenia Ulzurrun; Camilla Stephens; Francisco Ruiz-Cabello; Mercedes Robles-Diaz; Pablo Saenz-López; Hacibe Hallal; German Soriano; Eva Roman; M Carmen Fernandez; M Isabel Lucena; Raúl J Andrade
Journal:  PLoS One       Date:  2014-04-14       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.